Search Articles


Recent News

Stephenson Cancer Center Affiliates with Sarah Cannon Research Institute to Expand Its Oncology Early-Phase Clinical Trials Program

The University of Oklahoma announced today that the Stephenson Cancer Center has affiliated with the Sarah Cannon Research Institute, one of the nation’s largest clinical trials and research management programs. This affiliation, the first academic affiliation for the Tennessee-based institute, will provide the Stephenson Cancer Center with access to the Institute's large portfolio of early-phase oncology clinical trials. By participating in clinical trials research, especially early-phase or “phase I” clinical trials, cancer patients can gain first access to new cancer drugs.

Read more >
Clinical Trial Finds Breakthrough for Survivors

If given the choice, most cancer survivors would choose less time in the hospital, less time recovering from surgery and more time enjoying life. Now, a decade’s worth of research funded by the National Cancer Institute and conducted by the Gynecologic Oncology Group at the University of Oklahoma Health Sciences Center, has provided that choice. The study, which appears this month in the Journal of Clinical Oncology, found that laparoscopic surgery for uterine cancer is a better choice than traditional open surgery for most women. It is good news for the more than 40,000 women each year who are diagnosed with the deadly disease.

Read more >